# Firdapse

NDC: 69616-211
Generic name: amifampridine phosphate
Labeler / Manufacturer: Catalyst Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190107

FDA application: NDA208078

## Active ingredients

- AMIFAMPRIDINE PHOSPHATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69616-211"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69616-211
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f015fe60-3128-4a43-8c31-19fc6b5def3f